REFERENCES
- Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 Feb; 4(2):295–306.
- Sène D, Piette JC, Cacoub P. Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmun Rev. 2008 Feb; 7(4):272–277. Epub 2007 Oct 23.
- Cervera R, Asherson RA. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics. Immunobiology. 2005; 210(10):735–741. Epub 2005 Oct 21. Review.
- Skouri H, Gandouz R, Kraiem I, Harrabi I, Ben Said M. Antibodies to anionic phospholipids and cofactors in kala-azar: comparative study with malaria, toxoplasmosis and “autoimmune diseases.” Clin Exp Rheumatol. 2008 Sep–Oct; 26(5):894–902.
- Zinger H, Sherer Y, Goddard G, et al. Common infectious agents prevalence in antiphospholipid syndrome. Lupus. 2009 Nov; 18(13):1149–1153.
- Gentile RC, Berinstein DM, Oppenheim R, Walsh JB. Retinal vascular occlusions complicating acute toxoplasmicretinochoroiditis. Can J Ophthalmol. 1997 Aug;32(5):354–358.
- Suvajac G, Stojanovich L, Milenkovich S. Ocular manifestations in antiphospholipid syndrome. Autoimmun Rev. 2007 Jun; 6(6):409–414. Epub 2006 Dec 20. Review.